市場調査レポート - 232610

米国の止血診断市場の将来展望

The 2012 US Hemostasis Market

発行 Venture Planning Group
出版日 ページ情報 英文
価格
こちらの商品の販売は終了いたしました。
米国の止血診断市場の将来展望 The 2012 US Hemostasis Market
出版日: 2012年03月28日 ページ情報: 英文

当商品の販売は、2012年07月23日を持ちまして終了しました。

アップデート版(商品コード:238193)が出版されております、詳細はお問い合わせください。

概要

当レポートでは、米国における止血診断関連市場について分析し、世界全体の技術・市場の最新動向、米国市場の現状と今後10年間の動向予測、市場拡大のための戦略と課題、主要企業プロファイルといった情報を盛り込んで、概略以下の構成でお届けします。

イントロダクション

世界市場と技術概要

  • 主な定期的・特殊止血検査
    • イントロダクション
    • APTT(活性化部分トロンボプラスチン時間)
    • α2抗プラズミン物質
    • 抗トロンビンIII
    • 出欠時間
    • D-ダイマー
    • エタノール凝固テスト
    • ユーグロブリン溶解
    • 因子測定
    • フィブリン分解物
    • フィブリノゲン(線維素原)
    • ヘパリン
    • ヒルジン
    • 凝血能亢進および血栓症
    • リポたんぱく質A
    • プラスミン
    • プラスミノゲン
    • プラスミノゲン活性化因子阻害因子(PAI)
    • 血小板機能検査
    • 血小板凝集
    • プロテインC&S
    • プロトロンビンフラグメント1.2
    • プロトロンビン時間(PT)
    • レプチラーセ時間
    • トロンビン時間
    • t-PA(組織型プラスミノゲン活性化因子)
    • フォン・ヴィレブランド因子
  • 各種装置のレビュー(全43種)
  • 主要な体外診断技術と潜在的な用途
    • 発色基質
    • モノクローナル抗体とポリクローナル抗体
    • 免疫学的検定
    • マイクロコンピュータ
    • オートメーション
    • ロボット工学
    • DNAプローブ
    • 人工知能
    • ドライケミストリー
    • バイオセンサー
  • 世界市場の概況
    • 事業環境
    • 市場構造
    • 市場規模・成長
    • ポイントオブケア(POC)検査市場

米国市場

  • エグゼクティブ・サマリー
  • ビジネス環境
    • 医療費支出
    • コスト意識
    • 医療費還付
    • 産業内の企業統合
    • マネージドケア(管理型医療)
    • 病院
    • 入院
    • 滞在期間
    • 産業の多様化
    • 医師の人口構成
    • 人口の高齢化
      • 慢性病
      • 発症率
      • 医原性への感受性
      • 複数疾患併発の事例
    • 研究機関に対する規制
  • 市場構造
  • 市場規模・成長率、主なサプライヤー

主な製品開発機会

分散型検査製品の設計基準

代替的な市場参入戦略

  • 内部開発
  • 協働事業協定
  • 大学との契約
  • 分散型検査市場の流通戦略
    • マーケティングのアプローチ
    • 製品の複雑性
    • 顧客の選好
    • 既存のサプライヤー
    • 新規参入サプライヤー
    • 主な種類の流通業者
    • 市場の分類

潜在的な市場参入障壁とリスク

  • 市場の成熟化
  • コスト抑制
  • 競争
  • 技術の限界
  • 特許保護
  • 規制による抑制
  • 分散型検査市場の課題

競合企業評価

  • Abbott
  • American Diagnostica
  • Avocet Medical
  • Axis-Shield
  • Beckman Coulter
  • Becton Dickinson
  • Bio/Data Corporation
  • Biosite
  • Chrono-Log
  • Corgenix Medical
  • Diagnostica Stago
  • Helena Laboratories
  • HYPEN BioMed
  • Instrumentation Laboratory
  • ITC
  • Nanogen
  • Roche
  • Siemens
  • Sienco
  • シスメックス
  • Thermo Fischer
  • Trinity Biotech
  • ZyCare

図表一覧

目次

Abstract

Description

Report Highlights:

  • Comprehensive 424-page analysis of the US hemostasis market.
  • Major issues pertaining to the US hemostasis laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years.
  • Ten-year volume and sales forecasts for 40 hemostasis procedures performed in US hospitals, commercial laboratories, and physician offices, including typical coagulation daily work loads.
  • Placement estimates for major automated and semi-automated systems.
  • Review of current instrumentation technologies, and a feature comparison of nearly 50 leading analyzers.
  • Ten-year reagent and instrument sales forecasts.
  • Sales and market shares of leading reagent and instrument suppliers.
  • Review of hemostasis technologies and their potential market applications.
  • Major opportunities for coagulation instruments and consumables.
  • Profiles of major current and emerging suppliers, including their sales, market shares, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies.
  • Business opportunities and strategic recommendations for instrument and reagent suppliers.

Contains: 424 pages and 18 tables.

Table of Contents

Introduction

Worldwide Market and Technology Overview

  • A. Major Routine and Special Hemostasis Tests
    • 1. Introduction
    • 2. Activated Partial Thromboplastin Time (APTT)
    • 3. Alpha-2 Antiplasmin
    • 4. Antithrombin III
    • 5. Bleeding Time
    • 6. D-Dimer
    • 7. Ethanol Flocculation Test
    • 8. Euglobulin Lysis
    • 9. Factor Assays
      • a. Introduction
      • b. Factor II
      • c. Factor V/Factor V Leiden
      • d. Factor VII
      • e. Factor VIII
      • f. Factor IX
      • g. Factor IXa
      • h. Factor X (Stuart Factor)
      • i. Factor Xa
      • j. Factor XI
      • k. Factor XII
      • l. Factor XIII
    • 10. Fibrin Degradation Products
    • 11. Fibrinogen
    • 12. Heparin
    • 13. Hirudin
    • 14. Hypercoagulability and Thrombosis
    • 15. Lipoprotein a
    • 16. Plasmin
    • 17. Plasminogen
    • 18. Plasminogen Activator Inhibitor (PAI)
    • 19. Platelet Function Tests
    • 20. Platelet Aggregation
    • 21. Proteins C and S
    • 22. Prothrombin Fragment 1.2
    • 23. Prothrombin Time (PT)
    • 24. Reptilase Time
    • 25. Thrombin Time
    • 26. Tissue-Type Plasminogen Activator (t-PA)
    • 27. Von Willebrand's Factor
  • B. Instrumentation Review
    • Introduction
    • Benk Hemolab
    • Benk TRT Thrombotimer
    • Bio/Data MCA 310
    • Bio/Data MCA 210
    • Bio/Data PAP-4C D/4D/4C
    • Cardiovascular Diagnostics COAG
    • Diagnostica Stago STA Compact
    • Diagnostica Stago STA-R
    • Diagnostica Stago Star 4/8
    • Helena Laboratories Cascade 480
    • Helena Laboratories Cascade M
    • Helena Laboratories PACKS-4
    • Helena THOR
    • Instrumentation Laboratory ACL 100 and 1000 series
    • Instrumentation Laboratory ACL6000
    • Instrumentation Laboratory ACL7000
    • Instrumentation Laboratory ACL9000
    • Instrumentation Laboratory Electra 1000C
    • Instrumentation Laboratory Electra 1400C
    • Instrumentation Laboratory Electra 1600/C
    • Instrumentation Laboratory Electra 1800C
    • Instrumentation Laboratory Futura
    • ITC Hemochron 8000
    • Roche Diagnostics CoaguChek
    • Siemens BCS
    • Siemens BCT
    • Siemens BF II/Fibrintimer Series
    • Sysmex CA-50
    • Sysmex CA-500
    • Sysmex CA-1500
    • Sysmex CA-5000/CA-1000
    • Sysmex CA-6000
    • Sysmex CA-7000
    • Teco Coatron II/Jr./AccuStasis 5000
    • Trinity Biotech Amax CS190
    • Trinity Biotech Amax CS400
    • Trinity Biotech Coag-A-Mate Max
    • Trinity Biotech KC 40, 4A, 1A Series
    • Trinity Biotech MDA 180
    • Trinity Biotech Coag-A-Mate MTX
    • Trinity Biotech Coag-A-Mate RA4
    • Trinity Biotech Coag-A-Mate XC/Plus
    • Trinity Biotech Coag-A-Mate XM
  • C. Major in Vitro Diagnostic Technologies and Their Potential Applications
    • 1. Chromogenic Substrates
    • 2. Monoclonal and Polyclonal Antibodies
    • 3. Immunoassays
      • a. Applications
      • b. Technological Principle
      • c. Enzyme Immunoassays (EIA)
        • Overview
        • ELISA
        • EMIT
        • Dot Immunobinding Assays
        • Capillary Immunoassays
        • Enzyme Amplification
        • Electrochemical Immunoassay
      • d. Fluorescent Immunoassays
        • Fluorescence Polarization
        • Time-Resolved Pulse Fluorescence
        • Fluorescence Lifetime
      • e. Latex Agglutination
      • f. Immunoprecipitation
    • 4. Microcomputers
    • 5. Automation
    • 6. Robotics
    • 7. DNA Probes
      • a. Overview
      • b. Amplification Methods
        • PCR
        • Ligase Chain Reaction
        • Branched DNA
        • Q-Beta Replicase
        • NASBA
        • SDA
        • 3 SR
        • HPA
        • Two-Tiered System
        • LAT
    • 8. Artificial Intelligence
    • 9. Dry Chemistry
    • 10. Biosensors
  • D. Worldwide Market Overview
    • 1. Business Environment
    • 2. Market Structure
    • 3. Market Size and Growth
    • 4. POC Testing Market

USA

  • A. Executive Summary
  • B. Business Environment
    • 1. Health Care Expenditures
    • 2. Cost Consciousness
    • 3. Industry Consolidation
    • 4. Managed Care
    • 5. Hospitals
    • 6. Admissions
    • 7. Length of Stay
    • 8. Industry Diversification
    • 9. Physician Demographics
    • 10. Population Aging
      • a. Chronic Illnesses
      • b. Disease Incidence
      • c. Susceptibility to Iatrogenesis
      • d. Multiple Illness Cases
    • 11. Laboratory Regulations
  • C. Market Structure
    • 1. Centralized Testing
      • a. Hospitals
      • b. Commercial laboratories
    • 2. Decentralized Testing
      • a. Physician Offices/Group Practices
      • b. Point-of-Care Testing
      • c. Home/Self Testing
      • d. Other Decentralized Testing Locations
  • D.Market Size, Growth And Major Suppliers

Major Product Development Opportunities

Design Criteria For Decentralized Testing Products

Alternative Market Penetration Strategies

  • A. Internal Development
  • B. Collaborative Arrangements
  • C. University Contracts
  • D. Distribution Strategies for Decentralized Testing Markets
    • 1. Marketing Approaches
    • 2. Product Complexity
    • 3. Customer Preference
    • 4. Established Suppliers
    • 5. Emerging Suppliers
    • 6. Major Types Of Distributors
    • 7. Market Segmentation

Potential Market Entry Barriers and Risks

  • A. Market Maturity
  • B. Cost Containment
  • C. Competition
  • D. Technological Edge and Limitations
  • E. Patent Protection
  • F. Regulatory Constraints
  • G.Decentralized Testing Market Challenges

Competitive Assessments

  • Abbott
  • American Diagnostica
  • Avocet Medical
  • Axis-Shield
  • Beckman Coulter
  • Becton Dickinson
  • Bio/Data Corporation
  • Biosite
  • Chrono-Log
  • Corgenix Medical
  • Diagnostica Stago
  • Helena Laboratories
  • HYPEN BioMed
  • Instrumentation Laboratory
  • ITC
  • Nanogen
  • Roche
  • Siemens
  • Sienco
  • Sysmex
  • Thermo Fischer
  • Trinity Biotech
  • ZyCare

List of Tables

  • Major Companies Developing or Marketing Activated Clotting Time Tests
  • Major Companies Developing or Marketing APTT Tests
  • Major Companies Developing or Marketing Alpha-2 Antiplasmin Tests
  • Major Companies Developing or Marketing Antithrombin III Tests
  • Major Companies Developing or Marketing Bleeding Time Tests
  • Major Companies Developing or Marketing D-dimer Tests
  • Major Companies Developing or Marketing Factor Assays
  • Major Companies Developing or Marketing Fibrin Degradation Product Tests
  • Major Companies Developing or Marketing Fibrinogen Tests
  • Major Companies Developing or Marketing Heparin Tests
  • Major Companies Developing or Marketing Plasmin Tests
  • Major Companies Developing or Marketing Plasminogen Tests
  • Major Companies Developing or Marketing Plasminogen Activator Inhibitor Tests
  • Major Companies Developing or Marketing Platelet Aggregation Tests
  • Major Companies Developing or Marketing Protein C Tests
  • Major Companies Developing or Marketing Protein S Tests
  • Major Companies Developing or Marketing PT Tests
  • Major Companies Developing or Marketing Thrombin Time Tests
  • Major Companies Developing or Marketing TPA Tests
  • Major Companies Developing or Marketing Von Willebrand's Factor Tests
  • Worldwide, All Market Segments, Laboratories Performing Hemostasis Tests By Country, 2010
  • Worldwide, All Market Segments, Total Hemostasis Test Volume By Country, 2010-2020
  • Worldwide, All Market Segments, Total Hemostasis Reagent Market By Country, 2010-2020
  • Worldwide, All Market Segments, Total Hemostasis Instrument Market By Country, 2010-2020
  • Worldwide, All Market Segments, Total Hemostasis Diagnostics Market By Country, 2010-2020
  • Executive Summary Table: U.S.A., Total Hemostasis Diagnostics Market By Market Segment and Product Category, 2010-2020
  • U.S.A., Laboratories Performing Hemostasis Tests By Market Segment, 2010
  • U.S.A., Hospital Laboratories Performing Hemostasis Tests By Bed Size, 2010
  • U.S.A., Commercial/Private Laboratories Performing Hemostasis Tests By Annual Test Volume, 2010
  • U.S.A., Physician Offices/Group Practices Performing Hemostasis Tests By Practice Size, 2010
  • U.S.A., Hospital Laboratories Average Daily Test Volume, 2010
  • U.S.A., Commercial/Private Laboratories Average Daily Test Volume, 2010
  • U.S.A., Physician Offices/Group Practices Average Daily Test Volume
  • U.S.A., Total Hemostasis Test Volume By Market Segment, 2010-2020
  • U.S.A., All Market Segments Hemostasis Test Volume, 2010-2020
  • U.S.A., Hospital Laboratories Hemostasis Test Volume, 2010-2020
  • U.S.A., Physician Offices/Group Practices Hemostasis Test Volume, 2010-2020
  • U.S.A., Commercial/Private Laboratories Hemostasis Test Volume, 2010-2020
  • U.S.A., Hemostasis Reagent Market By Market Segment, 2010-2020
  • U.S.A., Major Suppliers of Hemostasis Reagents Estimated Sales and Market Shares, 2010
  • U.S.A., Hemostasis Instrument Market By Market Segment, 2010-2020
  • U.S.A., Major Suppliers of Hemostasis Analyzers, Estimated Total Instrument Placements and Market Shares, 2010
  • U.S.A., Major Suppliers of Hemostasis Analyzers, Estimated Placements and Installed Base By Supplier and Model, 2010
  • U.S.A., Major Suppliers of Hemostasis Analyzers, Estimated Instrument Sales and Market Shares, 2010
  • U.S.A., Total Hemostasis Diagnostics Market By Product Category, 2010-2020
  • U.S.A., Major Suppliers of Hemostasis Diagnostic Products, Estimated Sales and Market Shares, 2010
Back to Top